Neuroepithelioma  >>  Imlygic (talimogene laherparepvec) 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Imlygic (talimogene laherparepvec) / Amgen
NCT02147951: Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

No Longer Available
3b
US
Talimogene Laherparepvec
Amgen
Unresected Stage IIIb to IVM1c Melanoma
 
 

Download Options